Document is current
Any future updates will be listed below
-
Authors
Shoumariyeh, Khalid https://orcid.org/0000-0001-7969-1972
Haug, Stefan
Schwaab, Juliana
Pfeil, Julie K. https://orcid.org/0009-0001-1015-5052
Stappenbeck, Jannis
Schmitt-Graeff, Annette
Naumann, Nicole
Waltemode, Greta
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
Miething, Cornelius https://orcid.org/0000-0003-4699-3805
Hofmann, Wolf-Karsten
Meggendorfer, Manja https://orcid.org/0000-0002-9038-3265
Diederichs, Sven https://orcid.org/0000-0001-7901-4752
Duyster, Justus https://orcid.org/0000-0001-7325-7753
Reiter, Andreas
- License Information
-
More Information
Article History
Received: 11 December 2025
Revised: 16 January 2026
Accepted: 2 February 2026
First Online: 20 February 2026
Competing interests
: JSc and AR received research funding from Incyte. RZ received speaker fees from Novartis, Sanofi, Medac, Neovii, and Therakos. SD receives research funding from BioMarin and is co-owner of siTOOLs Biotech GmbH, Martinsried, unrelated to this work. KS, SH, JKP, JSt, ASG, NN, GW, CM, WKH, MM, and JD have no financial or other relationships that might lead to a conflict of interest.
